Genetics of lupus nephritis
The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Susceptibility to lupus nephritis is the end-result of complex interactions between polymorphic genetic factors involved in the regulation of immune responses. In humans, genome-wide screens and candidate-gene analyses led to the identification of several loci containing potential targets (FcgRIIa, PTPN22, PD-1, IL-10) for physiopathological research and therapeutic interventions. In mice, the generation of congenic mice, bearing in a normal genetic background one single disease-associated locus, greatly improved our understanding of the mechanisms mediating the genetic contribution to the disease. In the future, the identification of disease-associated genes will open new perspectives for the development of more targeted therapies of lupus nephritis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mycophenolate mofetil (MMF), a compound that inhibits type II inosine monophosphate dehydrogenase and thus suppresses proliferation of T and B cells (43).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [43]
Citations
Cites
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., et al. (2000) · Nature · doi:10.1038/35010115 · Cited by 1,174
BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator
Moore, P. A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D. W., Feng, P., Soppet, D., Charters, M., Gentz, R., Parmelee, D., et al. (1999) · Science · doi:10.1126/science.285.5425.260 · Cited by 1,144
Cheema, G. S., Roschke, V., Hilbert, D. M., & Stohl, W. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1313::aid-art223>3.0.co;2-s · Cited by 802
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789
Prokunina, L., Castillejo-López, C., Öberg, F., Gunnarsson, I., Berg, L., Magnusson, V., Brookes, A. J., Tentler, D., Kristjansdóttir, H., Gröndal, G., et al. (2002) · Nature Genetics · doi:10.1038/ng1020 · Cited by 769
Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus
Zhang, J., Roschke, V., Baker, K. P., Wang, Z., Alarcón, G. S., Fessler, B. J., Bastian, H., Kimberly, R. P., & Zhou, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.6 · Cited by 734
Taylor, P. R., Carugati, A., Fadok, V. A., Cook, H. T., Andrews, M., Carroll, M. C., Savill, J. S., Henson, P. M., Botto, M., & Walport, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.359 · Cited by 729
Research works printed but not linked: 18
- Sullivan KE, 1994, J Rheumatol, 21, 1128
- 10.1002/1529-0131(199909)42:9<1902::AID-ANR16>3.0.CO;2-G · DOI · Paper page
- 10.1002/1529-0131(200102)44:2<361::AID-ANR54>3.0.CO;2-G · doi:10.1002/1529-0131(200102)44:2<361::aid-anr54>3.0.co;2-g
- 10.1002/1529-0131(200012)43:12<2793::AID-ANR20>3.0.CO;2-6 · doi:10.1002/1529-0131(200012)43:12<2793::aid-anr20>3.0.co;2-6
- 10.1002/1529-0131(199909)42:9<1908::AID-ANR17>3.0.CO;2-7 · DOI · Paper page
- Criswell LA, 2000, J Clin Invest, 105, 1501
- 10.1002/1529-0131(199910)42:10<2194::AID-ANR22>3.0.CO;2-U · doi:10.1002/1529-0131(199910)42:10<2194::aid-anr22>3.0.co;2-u
- 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2 · doi:10.1002/1529-0131(200112)44:12<2819::aid-art469>3.0.co;2-2
- 10.1002/1529-0131(199809)41:9<1652::AID-ART17>3.0.CO;2-W · doi:10.1002/1529-0131(199809)41:9<1652::aid-art17>3.0.co;2-w
- 10.1002/(SICI)1521-4141(199812)28:12<4257::AID-IMMU4257>3.0.CO;2-H · DOI · Paper page
- 10.1002/1521-4141(200002)30:2<356::AID-IMMU356>3.0.CO;2-H · doi:10.1002/1521-4141(200002)30:2<356::aid-immu356>3.0.co;2-h
- 10.1002/1529-0131(200002)43:2<349::AID-ANR14>3.0.CO;2-M · doi:10.1002/1529-0131(200002)43:2<349::aid-anr14>3.0.co;2-m
- Giraldo P, 2001, Transgenic Res, 50, 26
- 10.1086/423790 · DOI · Paper page
- 10.1172/JCI200419139 · doi:10.1172/jci200419139 · Paper page
- 10.1002/(SICI)1521-4141(199910)29:10<3168::AID-IMMU3168>3.0.CO;2-H · doi:10.1002/(sici)1521-4141(199910)29:10<3168::aid-immu3168>3.0.co;2-h
- 10.1073/pnas.97.7.3370 · doi:10.1073/pnas.97.7.3370 · Paper page
- Iizuka J, 1998, Lab Invest, 78, 1523
Cited by
Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Liu, Z., & Davidson, A. (2012) · Nature Medicine · doi:10.1038/nm.2752 · Cited by 433
The innate immune system in SLE: type I interferons and dendritic cells
Rönnblom, L., & Pascual, V (2008) · Lupus · doi:10.1177/0961203308090020 · Cited by 312
Systemic lupus erythematosus: all roads lead to type I interferons
Pascual, V., Farkas, L., & Banchereau, J. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.014 · Cited by 285
“Even though they display high autoantibody titers, these mice do not develop further SLE manifestations unless crossed with mice carrying other lupus-prone genetic intervals (reviewed in [68]).”
BackgroundEarly, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model
Rowland, S. L., Riggs, J. M., Gilfillan, S., Bugatti, M., Vermi, W., Kolbeck, R., Unanue, E. R., Sanjuan, M. A., & Colonna, M. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132620 · Cited by 281
“Disease susceptibility in BXSB is linked to several genetic loci, particularly the telomeric region of chromosome 1, which encodes Fcr2b, Ifi202, and SLAM/ CD2 family members (Morel et al., 2001; Lauwerys and Wakeland, 2005; Fairhurst et al., 2006; Haywood et al., 2006; Theofilopoulos et al., 2010).”
BackgroundGreen, R. S., Stone, E. L., Tenno, M., Lehtonen, E., Farquhar, M. G., & Marth, J. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.008 · Cited by 162
“a high prevalence of kidney disease (Jorgensen et al., 2004; Lauwerys and Wakeland, 2005).”
Background
Metadata
- Authors
- Lauwerys, B. R., & Wakeland, E. K.
- Affiliations
- Cliniques Universitaires Saint-Luc (BE)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lauwerys, B R
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2005-01
- Volume
- 14
- Issue
- 1
- Pages
- 2-12
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W1969456998
- Cited by
- 42
- References
- 105
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 2 · 2020: 1 · 2017: 1 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Keywords
- lupus nephritis, genetic susceptibility, immune regulation, FCGR2A, PTPN22, PD-1, IL-10, disease-associated loci, congenic mice, targeted therapy
- MeSH terms
- Animals, Genetic Testing, Humans, Lupus Nephritis, Genetic Predisposition to Disease, Models, Animal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetics of lupus nephritis. https://app.cochat.ai/papers/10.1191/0961203305lu2052oa
- The paper
- Lauwerys, B. R., & Wakeland, E. K. (2005). Genetics of lupus nephritis. Lupus. https://doi.org/10.1191/0961203305lu2052oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.